Idalbi Tablet 20 Milligrams (Azilsartan Medoxomil Potassium)

Adult dosage

The recommended initial dose of this medication is 40 milligrams once a day, administered regardless of meals. If blood pressure is not adequately controlled at this dose, it can be increased up to 80 milligrams per day. In elderly patients aged 75 years and older, an initial dose of 20 milligrams may be considered. For patients with mild to moderate liver impairment and decreased effective intravascular blood volume, an initial dose of 20 milligrams is also recommended.

Children's dosage

The safety and efficacy of this medication in children and adolescents under the age of 18 have not been established.

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so if pregnancy is confirmed, it should be discontinued immediately. Patients who are allergic to any component of this medication, pregnant women, and patients with certain impaired kidney function should not take it. Patients with congestive heart failure, severe renal impairment, or renal artery stenosis should use this medication with caution and should be monitored regularly for blood pressure and kidney function. Patients with dehydration or reduced salt levels may experience hypotension symptoms upon initial use, so caution is required. Since there is a risk of elevated potassium levels, those taking potassium-sparing diuretics, potassium supplements, etc., should regularly check their blood potassium levels. Common side effects of this medication include dizziness and hypotension, so caution should be exercised when driving or operating hazardous machinery. There may be interactions if taken with lithium medications or non-steroidal anti-inflammatory drugs, so consultation with a healthcare provider is necessary. Women who are breastfeeding are advised to avoid this medication, and if they are taking it, they should discontinue breastfeeding or consult a doctor. In case of overdose, symptoms like hypotension and dizziness may occur, so if symptoms are severe, immediately visit a medical facility. This medication should be stored out of the reach of children, kept away from light and moisture, and retained in its original packaging.

Serious side effects

• Urticaria
• angioedema
• hypotension
• acute kidney injury
• respiratory distress
• subdural hematoma
• syncope
• complete heart block

Mild side effects

• Dizziness
• headache
• diarrhea
• nausea
• rash
• itching
• muscle cramps
• fatigue
• peripheral edema
• increased serum creatine phosphokinase

This medication should be stored in a sealed container that does not allow light to enter, preferably at a temperature between 1 to 30 degrees Celsius. Additionally, it should be stored in a dry place to effectively maintain the medication's efficacy.

Appearance

White or almost white round tablet

Package unit

28 tablets/PTP [(14 tablets * 2ea)]